PDF) BPC 157: Mechanisms, Dosing Protocols, and Quality Considerations for Research Use Thinking about BPC 157? Read this first. 5 things to know before your first reconstitution what it actually does, the standard dose, the rest day mistake most people skip, and the legal status BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 Rapid Release Renewed Vitality BPC 157 5mg Particle Peptides